Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Operative Detection of Occult Ovarian Carcinoma Using Folate-FITC
NCT01511055Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of EC-17 in ovarian cancer, sponsored by Mayo Clinic. Primary endpoint: Sensitivity and Specificity of Intra-operative Imaging Using Folate-FITC for Identification of Ovarian Cancer Metastatic to the Peritoneum and Lymph Nodes at 1 week. Started Jan 2012; status: terminated.
02
Drugs
EC-17
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01511055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511055.